Dae Hyeok Yang
Overview
Explore the profile of Dae Hyeok Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
504
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Hyun H, Yoo Y, Kim S, Ko H, Chun H, Yang D
Int J Mol Sci
. 2019 Sep;
20(19).
PMID: 31547111
We used a hydrogel-mediated dual drug delivery approach, based on an injectable glycol chitosan (GC) hydrogel, doxorubicin hydrochloride (DOX⋅HCl), and a complex of beta-cyclodextrin (β-CD) and paclitaxel (PTX) (GDCP) for...
22.
Lee S, Jung J, Jo G, Yang D, Koh Y, Hyun H
Cancers (Basel)
. 2019 Sep;
11(9).
PMID: 31480639
A Photothermal therapy (PTT) using a near-infrared (NIR) heptamethine cyanine fluorophore has emerged as an alternative strategy for targeted cancer therapy. NIR fluorophores showing a high molar extinction coefficient and...
23.
Lim W, Kim B, Jo G, Yang D, Park M, Hyun H
Lasers Med Sci
. 2019 Jun;
35(1):115-120.
PMID: 31154597
Bioluminescence imaging is being increasingly utilized in biological research. However, since the most commonly used firefly luciferase generates relatively weak bioluminescent signals, detection of low numbers of luciferase-expressing cells in...
24.
Lee D, Hyun H, Lee S, Kim S, Kim G, Um S, et al.
Mar Drugs
. 2019 Jan;
17(1).
PMID: 30641942
Bisphosphonates (BPs) used for treating skeletal diseases can induce bisphosphonate-related osteonecrosis of the jaw (BRONJ). Despite much effort, effective remedies are yet to be established. In the present study, we...
25.
Hyun H, Park M, Jo G, Kim S, Chun H, Yang D
Mar Drugs
. 2019 Jan;
17(1).
PMID: 30634553
In this study, we prepared an injectable drug delivery depot system based on a visible light-cured glycol chitosan (GC) hydrogel containing paclitaxel (PTX)-complexed beta-cyclodextrin (β-CD) (GC/CD/PTX) for ovarian cancer (OC)...
26.
Kim C, Park S, Yang D, Chun H
Adv Exp Med Biol
. 2018 Oct;
1077:475-485.
PMID: 30357704
Chitosan, a deacetylated chitin, is one of the few natural polymers similar to glycosaminoglycans (GAGs) widely distributed throughout connective tissues. It has been believed that the excellent biocompatibility of chitosan...
27.
Yoon S, Yoo Y, Nam S, Hyun H, Lee D, Um S, et al.
Mar Drugs
. 2018 Sep;
16(10).
PMID: 30257482
Bone tissue engineering scaffolds offer the merits of minimal invasion as well as localized and controlled biomolecule release to targeted sites. In this study, we prepared injectable hydrogel systems based...
28.
Yoo Y, Yoon S, Kim S, Lee D, Um S, Hyun H, et al.
Drug Deliv
. 2018 Sep;
25(1):1664-1671.
PMID: 30183420
Systemic drug delivery systems (SDDSs) for thyroid cancer treatment are associated with serious side effects including nausea, anorexia, and hair loss as a result of damage to normal tissues. In...
29.
Hyun H, Park M, Lim W, Kim S, Jo D, Jung J, et al.
Artif Cells Nanomed Biotechnol
. 2018 May;
46(sup2):874-882.
PMID: 29749265
Currently available chemotherapy is associated with serious side effects, and therefore novel drug delivery systems (DDSs) are required to specifically deliver anticancer drugs to targeted sites. In this study, we...
30.
Kim E, Yang D, Lee D
J Nanosci Nanotechnol
. 2018 Apr;
17(2):998-1007.
PMID: 29671974
In this study we report on the effectiveness of click chemistry-enhanced zirconium dioxide (ZrO2-3) for the immobilization of biomolecules, and the enhancement of osteoblastic differentiation of MC3T3-E1 cells by bone...